Submissions for variant NM_001267550.2(TTN):c.31426+1G>C

gnomAD frequency: 0.00001  dbSNP: rs6749719

Total submissions: 4

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000040119	SCV000063810	uncertain significance	not specified	2012-03-14	criteria provided, single submitter	clinical testing	Variant classified as Uncertain Significance - Favor Pathogenic. The 27694+1G>C variant in TTN has not been previously identified by our laboratory but is liste d in dbSNP (rs6749719) without frequency information. This variant is predicted to cause abnormal splicing because the nucleotide substitution occurs in the hig hly conserved splice consensus sequence resulting in an abnormal or absent prote in. Loss-of-function variants in TTN are common in patients with DCM (Herman 201 2), though their role in HCM is unclear. In addition, variants in TTN are also associated with several myopathies (Hackman 2002, Hackman 2008, www.OMIM.org). A lthough this variant is predicted to have a severe impact on the protein, additi onal studies are needed to determine if this is contributes to this patient's cl inical features.
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust	RCV000209261	SCV000189730	uncertain significance	Primary dilated cardiomyopathy	2014-10-08	criteria provided, single submitter	research	This TTN truncating variant (TTNtv) was identified in one individual in this cohort and is located in an exon with intermediate levels of cardiac expression. In the seven cohorts assessed, TTNtv were found in 14% of ambulant DCM, 22% end-stage or familial DCM, and 2% controls. Heterozygous nonsense, frameshift and canonical splice-disrupting variants found in constitutive and other highly utilised exons are highly likely to be pathogenic when identified in individuals with phenotypically confirmed DCM. TTNtv found incidentally in healthy individuals (excluding familial assessment of DCM relatives) are thought to have low penetrance, particularly when identified in exons that are not constitutively expressed in the heart.
Labcorp Genetics (formerly Invitae), Labcorp	RCV000560902	SCV000642967	uncertain significance	Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J	2023-09-08	criteria provided, single submitter	clinical testing	In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been shown to be highly prevalent in the general population and unaffected individuals (PMID: 26701604, 22335739). However, truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 46849). Disruption of this splice site has been observed in individual(s) with dilated cardiomyopathy (PMID: 25589632). This variant is present in population databases (rs6749719, gnomAD 0.002%). This sequence change affects a donor splice site in intron 117 of the TTN gene. It is expected to disrupt RNA splicing and likely results in a truncated or disrupted TTN protein.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000040119	SCV004804164	uncertain significance	not specified	2024-01-04	criteria provided, single submitter	clinical testing	Variant summary: TTN c.27694+1G>C is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: three predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. In addition, the PSI value (proportion spliced-in) for the neighboring symmetric exon is intermediate (www.cardiodb.org), therefore the significance of this splice variants is unclear. The variant allele was found at a frequency of 2.4e-05 in 1,545,502 control chromosomes (i.e. in 37 carriers) in the gnomAD database (v4.0 dataset). The variant, c.27694+1G>C, has been reported in heterozygous state in a few individuals affected with various cardiac and neuromuscular phenotypes, however it was also found in several (apparently) healthy controls (e.g. Roberts_2015, Choi_2018, Rich_2020, Jurgens_2022). These reports do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Type 2J. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25589632, 31691645, 32815318, 35177841). ClinVar contains an entry for this variant (Variation ID: 46849). Based on the evidence outlined above, the variant was classified as uncertain significance.